comparemela.com

Latest Breaking News On - National reimbursement drug list - Page 2 : comparemela.com

Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Israel
China
South-korea
Tsadal
Kyongsang-bukto
United-kingdom
Boston
Massachusetts
United-states
Richard-paulson
Drug-administration
Prnewswire-karyopharm-therapeutics-inc

Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates

Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Taiwan
Hong-kong
Macau
American
Andrew-zhu
Bristol-myers-squibb
Efgartigimod-fcrn
Xanomeline-trospium-kar
Simcere-zaiming
Josh-smiley

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript May 1, 2024 Amarin Corporation plc misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $-0.0075. AMRN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]

United-kingdom
Canada
China
United-states
Spain
Mark-marmur
Roanna-ruiz
Patrick-holt
Tom-reilly
United-kingdom-high-court
Cantor-fitzgerald
National-reimbursement-drug-list

Junshi Biosciences Announces NDA Acceptance in Hong Kong

SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading.

Maryland
United-states
United-kingdom
Beijing
China
San-francisco
California
Suzhou
Jiangsu
Singapore
Malaysia
Hong-kong-special-administrative-region

ASCO 2024 | Ascentage Pharma To Present Four Studies, Including An Oral Report Featuring The Latest Data Of Olverembatinib In SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma To Present Four Studies, Including An Oral Report Featuring The Latest Data Of Olverembatinib In SDH-Deficient GIST
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Melbourne
Victoria
Australia
Rockville
Illinois
United-states
Chicago
Guangdong
Jilin
China
Mccormick-place
Guangzhou
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.